4.7 Review

SARS-CoV-2 Entry Related Viral and Host Genetic Variations: Implications on COVID-19 Severity, Immune Escape, and Infectivity

期刊

出版社

MDPI
DOI: 10.3390/ijms22063060

关键词

SARS-CoV-2; COVID-19; spike glycoprotein; mutation; genetic variation; ACE2; variants; immune escape; transmissibility

资金

  1. Ministry of Science and Technology, R.O.C. [MOST 108-2320-B-037-035-MY3, 110-2918-I-037-002, MOST 109-2823-8-037-002-CV]
  2. Kaohsiung Medical University Research Center Grant (Drug Development and Value Creation Research Center) [KMU-TC109A03-6]

向作者/读者索取更多资源

The genetic diversity of SARS-CoV-2 and human populations plays a crucial role in determining the transmissibility and severity of COVID-19. The emergence of new variants with mutations in the spike protein could lead to immune escape and enhanced binding with ACE2, affecting virus entry into cells. Genetic variations in host proteins like ACE2 and TMPRSS2 may influence susceptibility to SARS-CoV-2 and impact the development of antiviral treatments and vaccines.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has evolved to display particular patterns of genetic diversity in the genome across geographical regions. These variations in the virus and genetic variation in human populations can determine virus transmissibility and coronavirus disease 2019 (COVID-19) severity. Genetic variations and immune differences in human populations could be the driving forces in viral evolution. Recently emerged SARS-CoV-2 variants show several mutations at the receptor binding domain in the spike (S) glycoprotein and contribute to immune escape and enhanced binding with angiotensin 1-converting enzyme 2 (ACE2). Since ACE2 and transmembrane protease serine 2 (TMPRSS2) play important roles in SARS-CoV-2 entry into the cell, genetic variation in these host entry-related proteins may be a driving force for positive selection in the SARS-CoV-2 S glycoprotein. Dendritic or liver/lymph cell-specific intercellular adhesion molecule (ICAM)-3-grabbing non-integrin is also known to play vital roles in several pathogens. Genetic variations of these host proteins may affect the susceptibility to SARS-CoV-2. This review summarizes the latest research to describe the impacts of genetic variation in the viral S glycoprotein and critical host proteins and aims to provide better insights for understanding transmission and pathogenesis and more broadly for developing vaccine/antiviral drugs and precision medicine strategies, especially for high risk populations with genetic risk variants.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据